Close Menu

Imperial College London

NEW YORK (GenomeWeb News) — Researchers have linked low copy-number levels of the salivary amylase gene to obesity risk, a finding they reported in Nature Genetics yesterday.

NEW YORK (GenomeWeb News) – A new Nature Genetics study hints that a combination of ineffective control strategies and new adaptations by Mycobacterium tuberculosis populations have con

NEW YORK (GenomeWeb News) – A New England Journal of Medicine study suggests high-risk variants in the apolipoprotein L1 gene APOL1 can contribute to more rapid kidney disease progression in individuals of A

NEW YORK (GenomeWeb News) – A blood-based gene expression signature is showing promise for detecting active tuberculosis in blood samples from individuals with or without concurrent HIV infections, according to new research.

A genome sequencing study in Nature offered hints about genetic strategies organisms may use to maintain species diversity, even in the absence of sexual repr

Skincare company GeneOnyx last week debuted an over-the-counter genetic analysis test for personalized skincare based on rapid DNA and RNA detection technology developed by partner DNA Electronics.

Researchers in the UK have compared a PCR-based and a capture hybridization-based assay for sequencing panels of inherited cardiovascular disease genes and have found both to be suitable for diagnostics in principle, though their sensitivity needs to be optimized.

NEW YORK (GenomeWeb News) – The UK's Engineering and Physical Sciences Research Council today announced a £5 million ($7.9 million) five-year grant to a consortium of universities to develop a Web-based synthetic biology platform.

Pages

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.